Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Aurigene details preclinical activity of anticancer compounds AU-18069 and AU-19820

April 27, 2021

Bayer discovers BCAT1/2 ihibitors

April 27, 2021

ER-alpha antagonists and SERDs patented by Sanofi

April 27, 2021

Bayer initiates first-in-human study of BAY-2666605 in metastatic melanoma and advanced solid tumors

April 26, 2021

New phase I/II trial evaluates OBI-3424 for relapsed or refractory T-ALL and T-LBL

April 26, 2021

Phase II trial evaluates ALX-148 with pembrolizumab for advanced HNSCC

April 26, 2021

PHI-101 studied in phase I trial for relapsed or refractory AML

April 26, 2021

Merck KGaA presents c-KIT inhibitors with strong antitumor activity in GIST

April 26, 2021

Shanghai De Novo Pharmatech discloses G12C mutant GTPase KRAS inhibitors

April 26, 2021

MAPK 8 inhibitors patented by Wuhan LL Science and Technology Development

April 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...